Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

That gives me 13 May plus the end of study evaluat

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 190)
Posted On: 03/16/2017 6:55:07 AM
Posted By: BooDog
Re: Chemdeps #32229
That gives me 13 May plus the end of study evaluation time for all the sites to compile and submit their data for review, maybe up to 6 weeks? The trial is slated for completion in July, my 6 weeks added takes me to 22 June.

Even though it's blind we should get somewhat of a bone at the half way point which imo, has just passed last week. Because it's so many sites, it may take a bit to get a full read so I think we need to be patient.

From the 10Q
The Company expects interim analysis top-line results in the second quarter of calendar 2017



December 19, 2016
Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites for Oral Prurisol Treatment of Moderate-To-Severe Psoriasis Initiated and Open for Screening

Prurisol
www.cellceutix.com/press-release/2016/12/19/cellceutix-reports-24-core-phase-2b-clinical-trial-sites-for-oral-prurisol-treatment-of-moderate-to-severe-psoriasis-initiated-and-open-for-screening


Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
https://clinicaltrials.gov/ct2/show/NCT029493...amp;rank=5


Quote:




Posted By: BooDog


Re: Chemdeps #32227


I think you're missing the screening 4 weeks and follow up 4 weeks.

https://clinicaltrials.gov/ct2/show/NCT029493...amp;rank=5




Quote:




Posted By: Chemdeps




Someone tell me if my math is correct....December 19th is when the P trial started (per CTIX PR issued that day)....84 days is the trial duration and that should have been March 13th (Monday). Compilation of results from the early participants should be ramping up, correct?


Read More: http://investorshangout.com/post/view?id=4417...z4bU8ezUVu



(4)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us